Abstract
Background/objective: Older age and male sex have been consistently found to be associated with dismal outcomes among COVID-19 infected patients. In contrast, premenopausal females present the lowest mortality among adults infected by SARS-CoV-2. The goal of the present study was to investigate whether peripheral blood type I interferon (IFN) signature and interleukin (IL)-6 serum levels -previously shown to contribute to COVID-19-related outcomes in hospitalized patients- is shaped by demographic contributors among COVID-19 convalescent individuals.
Patients and methods: Type I IFN-inducible genes in peripheral blood, as well as serum IL-6 levels were quantified in 61 COVID-19 convalescent healthy individuals (34 females, 27 males; age range 18-70 years, mean 35.7 ± 15.9 years) who recovered from COVID-19 without requiring hospitalization within a median of 3 months prior to inclusion in the present study. Among those, 17 were older than 50 years (11 males, 6 females) and 44 equal to or less than 50 years (16 males, 28 females). Expression analysis of type I IFN-inducible genes (MX-1, IFIT-1, IFI44) was performed by real time PCR and a type I IFN score, reflecting type I IFN peripheral activity, was calculated. IL-6 and C-reactive protein levels were determined by a commercially available ELISA.
Results: COVID-19 convalescent individuals older than 50 years exhibited significantly decreased peripheral blood type I IFN scores along with significantly increased IL-6 serum levels compared to their younger counterparts less than 50 years old (5.4 ± 4.3 vs 16.8 ± 24.7, p = 0.02 and 10.6 ± 16.9 vs 2.9 ± 8.0 ng/L, p = 0.03, respectively). Following sex stratification, peripheral blood type I IFN score was found to be significantly higher in younger females compared to both younger and older males (22.9 ± 29.2 vs 6.3 ± 4.6 vs 4.5 ± 3.7, p = 0.01 and p = 0.002, respectively). Regarding IL-6, an opposite pattern was observed, with the highest levels being detected among older males and the lowest levels among younger females (11.6 ± 18.9 vs 2.5 ± 7.8 ng/L, p = 0.03).
Conclusion: Constitutive higher type I IFN responses and dampened IL-6 production observed in younger women of premenopausal age, along with lower type I IFN responses and increased IL-6 levels in older males, could account for the discrete clinical outcomes seen in the two population groups, as consistently revealed in COVID-19 epidemiological studies.
Keywords: COVID-19; IL-6; type I interferon (IFN).
【저자키워드】 COVID-19, IL-6, type I interferon (IFN)., 【초록키워드】 Stratification, SARS-CoV-2, Mortality, Hospitalization, IL-6, Sex, C-reactive protein, outcome, hospitalized patients, ELISA, type I interferon, Peripheral blood, Clinical outcome, serum, interleukin, PCR, response, male, female, IFN, age, women, convalescent, real time PCR, Analysis, Male sex, real time, Type I IFN, blood type, determined by, population groups, Older, infected patients, Serum level, epidemiological studies, type I, serum levels, convalescent individuals, COVID-19 infected patients, Ifi44, opposite, Inclusion, females, males, significantly increased, lowest, IFN-inducible genes, convalescent individual, highest, shown, significantly, was performed, exhibited, median, calculated, less, contribute, significantly higher, groups, Type, IFN-inducible gene, healthy individual, quantified, IL-6 level, premenopausal female, 【제목키워드】 response, women, Older, Variability, men, convalescent individual, contribute,